Infographic
Boosting Bioavailability- How Companies are Using Advanced Technologies to Formulate Complex Molecules
Summary: This infographic focuses on evolving technologies that help overcome bioavailability challenges enabling the formulation of more complex molecules.
View Now
Offering Fact Sheet
OptiDose® Design Solution Capabilities Sheet
Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.
View Now
Case Study
Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening
Read this case study to learn how a team of bioavailability experts at Catalent took a target molecule from early stage to Phase 1 in under nine months.
View Now
Webinars
Reducing Inhalation Burden Through High-Dose, Carrier-Free Spray Dry Powders
Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions.
View Now
Infographic
Zydis® Orally Disintegrating Tablet (ODT) vs. Standard Tablets (ST)
Summary: This infographic provides a high level summary of studies comparing Zydis ODT against traditional oral tablets.
View Now
Webinars
High Potency Containment from Early Phase to Commercial Scale Micronization
Summary: In this webinar, learn more about enabling micronization of potent and highly potent compounds across the different stages of oral drug development
View Now
Executive Summary
Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules
Summary: Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.
View Now
Article
Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...
View Now
Webinars
Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms
Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.
View Now
Webinars
Strategies to Optimize the Dosage Form Design Process to Create Better Treatments
Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.
View Now